Myelodysplastic Syndromes (MDS)

Brady L. Stein, MD

Institution

Northwestern University Feinberg School of Medicine

Physician Status

accepting new patients

Primary Disease Area of Focus

Acute Myeloid Leukemia (AML)

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPN)

Read more about Brady L. Stein, MD

Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience

Read more about Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience

Background: Hematopoietic cell transplantation (HCT) remains the only curative therapy for pediatric myelodysplastic syndrome (MDS) in all but rare cases. While HCT outcomes for pediatric MDS are similar across the largest registry and single-center trials, factors identified as contributing to inferior outcomes vary from study to study. We performed an analysis to provide more clarity on the prognostic implications of disease characteristics, including blast burden and cytogenetic abnormalities, in the current era.

New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes

Read more about New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes

Recent advances in defining low- and intermediate-risk myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PL

Michael S. Samuel, MD

Institution

Weill Cornell Medicine

Physician Status

accepting new patients

Primary Disease Area of Focus

Acute Myeloid Leukemia (AML)

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPN)

Read more about Michael S. Samuel, MD

Jeanne M. Palmer, MD

Institution

Mayo Clinic, Phoenix, AZ

Physician Status

accepting new patients

Primary Disease Area of Focus

Graft Versus Host Disease (GVHD)

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPN)

Read more about Jeanne M. Palmer, MD

Yeung Chul Mun, MD

Institution

Ewha Woman's Medical Center Seoul Hospital

Primary Disease Area of Focus

Myelodysplastic Syndromes (MDS)

Read more about Yeung Chul Mun, MD

Adriana K Malone, MD

Institution

Icahn School of Medicine at Mount Sinai

Physician Status

accepting new patients

Primary Disease Area of Focus

Acute Myeloid Leukemia (AML)

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPN)

Read more about Adriana K Malone, MD

Leo Luznik, MD

Institution

Johns Hopkins University

Physician Status

accepting new patients

Primary Disease Area of Focus

Acute Myeloid Leukemia (AML)

Chronic Lymphocytic Leukemia (CLL)

Graft Versus Host Disease (GVHD)

Myelodysplastic Syndromes (MDS)

Read more about Leo Luznik, MD

Sydney X. Lu, MD

Institution

Stanford University School of Medicine

Physician Status

accepting new patients

Primary Disease Area of Focus

Acute Myeloid Leukemia (AML)

Chronic Lymphocytic Leukemia (CLL)

Myelodysplastic Syndromes (MDS)

Read more about Sydney X. Lu, MD

Taking Charge of My Care and Advocacy Following a Cancer Diagnosis

Original Publication Date

April 24, 2025

Article Source

External Web Content

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis. Almost every cancer survivor will agree that we end up going to too many doctors. A friend of mine with both cancer and diabetes…

Subscribe to Myelodysplastic Syndromes (MDS)

AAMDSIF Awareness Week

Myelodysplastic Syndromes (MDS)

Brady L. Stein, MD

Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience

New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes

Michael S. Samuel, MD

Jeanne M. Palmer, MD

Yeung Chul Mun, MD

Adriana K Malone, MD

Leo Luznik, MD

Sydney X. Lu, MD

Taking Charge of My Care and Advocacy Following a Cancer Diagnosis

Website Feedback